Objective: To study the efficiency and safety of PGE1 - CD intravenous infusion in the treatment of PAOD.
目的：临床评价静脉给保达新(PGE1·CD)治疗PAOD的有效性及安全性。
Conclusion Combined use of PGE1 with conventional therapy has much stronger efficacy in the treatment of secondary pulmonary hypertension.
结论在常规治疗的基础上联合使用PGE1可以明显降低继发性肺动脉高压。
Objective to determine the effectiveness and safety of PGE1 in patients with chronic renal failure (CRF) and to provide the proof of evidence-based pharmacy.
目的系统评价前列腺素e1治疗慢性肾功能衰竭的疗效和安全性，为临床选用前列腺素e1治疗该病提供循证药学证据。
METHOD: The investigation was carried out among 88 case of CLF who were divided at random into two group:acetylcysteine(treated group) and PGE1(control group).
方法：收治慢性重型肝炎88例，随机分为治疗组与对照组。
Conclusions PGE1 treatment during recipient operation could increase one-week survival rate, which might be related with its stabilizing effect on lysosome membrane.
结论术中应用PGE1能显著提高大鼠肝移植后的1周存活率，其机制可能与PGE1稳定溶酶体膜的作用有关。
Results PGE1 treated group had significantly higher levels of VEGF protein expression in the myocardium as compared to the control group and the sham-operation group(all P<(0.05). )
结果PGE1治疗组VEGF蛋白的表达、毛细血管密度、血浆VEGF浓度显著增加，明显高于对照组和假手术组（均P<0.05）。
The hemodynamic effects of prostaglandin E1(PGE1)on pulmonary and systemic circulations were studied in 11 patients with rheumatic mitral disease complicated by pulmonary hypertension.
应用漂浮导管监测前列腺素E1（PGE1）对11例以二尖瓣狭窄为主的风湿性心脏病合并肺动脉高压患者的体循环和肺循环的血液动力学作用。
Objective The purpose of this study was to evaluate the effect of prostaglandin E1 (PGE1) on blocking the development of acute respiratory distress syndrome (ARDS) induced by acid aspiration.
目的研究静脉注射前列腺素E1（PGE1）能否阻止酸吸入性急性呼吸窘迫综合征（ARDS）的发生。
Objective The purpose of this study was to evaluate the effect of prostaglandin E1 (PGE1) on blocking the development of acute respiratory distress syndrome (ARDS) induced by acid aspiration.
目的研究静脉注射前列腺素E1（PGE1）能否阻止酸吸入性急性呼吸窘迫综合征（ARDS）的发生。
应用推荐